Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Kyoko Miyagi"'
Autor:
Nanami Iwamura, Shuhei Kidoguchi, Nanae Asahi, Izumi Takeda, Kohei Matsuta, Kyoko Miyagi, Masayuki Iwano, Ryoichi Miyazaki, Hideki Kimura
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Patients on haemodialysis (HD) have high mortality risk, and prognostic values of the major cardiovascular biomarkers cardiac troponin I (cTnI), N-terminal pro-brain natriuretic peptide (NT-proBNP), and adiponectin should be ascertained over
Externí odkaz:
https://doaj.org/article/6e3c0720ac144c119b52865d071a9a40
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Background With the widespread use of the vaccine and the predominance of the Omicron strain, the number of patients presenting with typical coronavirus-infection disease 2019 (COVID-19) pneumonia on computed tomography (CT) has decreased dr
Externí odkaz:
https://doaj.org/article/44a6aa613fc64de892a059647764449a
Autor:
Shuhei Kidoguchi, Kunio Torii, Toshiharu Okada, Tomoko Yamano, Nanami Iwamura, Kyoko Miyagi, Tadashi Toyama, Masayuki Iwano, Ryoichi Miyazaki, Yosuke Shigematsu, Hideki Kimura
Publikováno v:
Diagnostics, Vol 14, Iss 20, p 2295 (2024)
Background/Objectives: Lipid metabolism and adiponectin modulate erythropoiesis in vitro and in general population studies and may also affect responsiveness to erythropoietin in patients undergoing haemodialysis (HD). However, little is known about
Externí odkaz:
https://doaj.org/article/2d6c36929f8b4025a6f3c418841eaf23
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Background Hemodialysis patients have chronic kidney disease, are often elderly, and have many complications such as hypertension, type 2 diabetes, cardiac disease, and cerebrovascular disease. Therefore, hemodialysis patients infected with
Externí odkaz:
https://doaj.org/article/8b744e9411634364ac3a809b97d18da3
Autor:
Ryoichi Miyazaki, Kyoko Miyagi
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Background Renal transplant recipients with chronic kidney disease often develop post-transplant diabetes mellitus or metabolic syndrome (MetS), which are poor prognostic factors after renal grafts. Although recent studies have reported the
Externí odkaz:
https://doaj.org/article/7140c12951b14b189d10712084e8b82f
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Background Hemodialysis patients are more likely to be severely affected if infected by COVID-19. Contributing factors include chronic kidney disease, old age, hypertension, type 2 diabetes, heart disease, and cerebrovascular disease. Theref
Externí odkaz:
https://doaj.org/article/61427f40348648df9ad5ae2b8841cffd
Autor:
Ryoichi Miyazaki, Kyoko Miyagi
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-6 (2022)
Abstract Background Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to exert cardiorenal protective effects in diabetic patients and are widely used clinically. In addition, an increasing number of reports now suggest these drugs ma
Externí odkaz:
https://doaj.org/article/8cb7c67acf5048f690fe0f8c360f18d9
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-8 (2020)
Abstract Background Renal transplant recipients with chronic kidney disease (CKD) often develop abnormal glucose metabolism. Although recent studies have reported the protective effects of sodium-glucose transport protein 2 (SGLT2) inhibitors on the
Externí odkaz:
https://doaj.org/article/d3d4f07126ea46d390a477cb8d6cc890
Autor:
Kaoru Kami-Onaga, Masao Tateyama, Takeshi Kinjo, Gretchen Parrott, Daisuke Tominaga, Ai Takahashi-Nakazato, Hideta Nakamura, Daisuke Tasato, Kyoko Miyagi, Saori Maeda, Hirotaka Arae, Hitoshi Uehara, Kazuya Miyagi, Shusaku Haranaga, Jiro Fujita
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0199106 (2018)
In this study, we demonstrated the pervasiveness of HIV-associated neurocognitive disorders (HAND) among a selection of Japanese patients as well as evaluated and compared the Mini Mental State Examination (MMSE) and the International HIV Dementia Sc
Externí odkaz:
https://doaj.org/article/4acce9d01355430f8cec30bd3af49cb3
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-8 (2020)
Background Renal transplant recipients with chronic kidney disease (CKD) often develop abnormal glucose metabolism. Although recent studies have reported the protective effects of sodium-glucose transport protein 2 (SGLT2) inhibitors on the heart and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd6e47239190dd4cec76e77a0584b783
https://doaj.org/article/d3d4f07126ea46d390a477cb8d6cc890
https://doaj.org/article/d3d4f07126ea46d390a477cb8d6cc890